Certain phenylethylamines, such as 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminop
ropane (DOB; 1a), are high-affinity 5-HT2 agonists. Previous structure-affi
nity studies have concluded that both the 2,5-dimethoxy substitution patter
n and the nature of substituents at the 4-position are important determinan
ts of high affinity. We recently demonstrated that replacement of the bromo
group of DOB with a 3-(phenyl)propyl substituent results in retention of a
ffinity and that, counter to established structure-affinity relationships,
the 2,5-dimethoxy substitution pattern is no longer a requirement for the b
inding. The present investigation extends these findings by examining a ser
ies of analogues, 3, lacking a 5-methoxy group. It was additionally found t
hat shifting the phenylalkyl substituent from the 4- to the 5-position (e.g
., 4i) also results in retention of affinity. For example, 1-(2-methoxy-5-(
3-phenylpropyl)-2-aminopropane (6; the alpha -methyl derivative of 4i) bind
s at 5-HT2A receptors with high affinity (K-i = 13 nM) and possesses 5-HT2A
antagonist character. Thus, not only is the 2,5-dimethoxy substitution pat
tern not a requirement for the binding of certain phenylethylamines at 5-HT
2A receptors, the presence of a 4-position substituent (previously thought
to serve as a modulator of affinity of DOB-like agents) is also not require
d. Striking differences in the 5-HT2A binding requirements of the present c
ompounds as compared to DOB-like agents suggest multiple substituent-depend
ent modes of binding.